Use of naringenin and naringin as transforming growth factor-β1 signaling pathway inhibitors

摘要

The present invention discloses the use of naringenin and naringin as inhibitors for transforming growth factor-²1 signaling pathway, especially the use of naringenin and naringin as inhibitors for transforming growth factor-²1 signaling pathway in the manufacture of medicaments for treating or preventing fibrosis and cancers.